Bruker BioSpin Corp

Description

“Bruker is dedicated to providing our customers with the flexibility and versatility they need to address modern analytical challenges. This agreement will serve to open up the choices laboratories have to select the preferred solutions that meet their needs.” said Joe Anacleto, Bruker Daltonics Vice President of the Applied, Industrial and Clinical Research Business Unit.

Professor Ilkka Ojanperä of the Laboratory of Forensic Toxicology at the University of Helsinki, said: “We have applied the bbCID concept using Bruker LC-TOF-MS for general forensic drug screening in urine since 2010. In 2013, we switched to the newest UHPLC-UHR-QTOF mass spectrometry technology to attain enhanced sensitivity for drugs-of-abuse and designer drug forensic screening, covering critical low concentration compounds like THC acid, buprenorphine, LSD, and synthetic cannabinoids.

Visit our Bruker training centers that run a comprehensive range of advances training courses covering topics such as system operation, maintenance and theory. We provide introductory classes as well as courses for advanced operators.

Life expectancy is increasing constantly around the world. Accordingly, an ever growing number of people are in need of medical devices such as arterial stents, orthopedic implants or even highly complex ophthalmics. Growing life spans pose a set of challenges to manufacturers of medical devices in terms of durability, service life, resilience, production capacity and thought leadership.

Fact sheet

Products & services

Similar companies nearby